Insider · CIK 0001869579

Imran Talat

Reports to the SEC for 1 company · SAN JOSE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001869579

Forms 4 and 5

Insider transactions

34 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-27	RANIRani Therapeutics Holdings, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−7,928 sh	$0.76	−$6,018.938	461,808
2026-07-17	RANIRani Therapeutics Holdings, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+35K sh	$0.72	+$25.2K	469,736
2026-06-27	RANIRani Therapeutics Holdings, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−7,927 sh	$0.74	−$5,865.98	434,736
2026-06-03	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+3.8M sh	—	—	3,800,000
2026-03-27	RANIRani Therapeutics Holdings, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−9,099 sh	$0.81	−$7,370.19	442,663
2026-03-22	RANIRani Therapeutics Holdings, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−8,916 sh	$1.13	−$10.1K	451,762
2025-12-27	RANIRani Therapeutics Holdings, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−7,906 sh	$1.40	−$11.1K	460,678
2025-09-27	RANIRani Therapeutics Holdings, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−9,077 sh	$0.48	−$4,356.96	468,584
2025-06-27	RANIRani Therapeutics Holdings, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−9,076 sh	$0.55	−$4,991.8	477,661
2025-05-23	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+1.05M sh	—	—	1,053,000
2024-12-27	RANIRani Therapeutics Holdings, Inc.S Sale	Director, Chief Executive Officer	SSale	−8,014 sh	$1.41	−$11.3K	486,737
2024-12-09	RANIRani Therapeutics Holdings, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+10.3K sh	$1.94	+$20K	494,751
2024-03-21	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+1.09M sh	—	—	1,085,000
2023-12-16	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−480K sh	—	—	95,933
2023-12-16	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+480K sh	—	—	479,667
2023-12-16	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−154K sh	—	—	109,750
2023-12-16	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+154K sh	—	—	153,650
2023-12-16	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−272K sh	—	—	453,125
2023-12-16	RANIRani Therapeutics Holdings, Inc. · 271875A Award	Director, Chief Executive Officer	AAward	+272K sh	—	—	271,875
2023-12-16	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−31.3K sh	—	—	47,699
2023-12-16	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+31.3K sh	—	—	31,252
2023-12-06	RANIRani Therapeutics Holdings, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+10K sh	$2.27	+$22.7K	484,455
2023-12-04	RANIRani Therapeutics Holdings, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+5,000 sh	$2.57	+$12.9K	474,455
2023-11-29	RANIRani Therapeutics Holdings, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+20K sh	$2.05	+$41K	469,455
2023-11-07	RANIRani Therapeutics Holdings, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+2,500 sh	$1.98	+$4,950	446,955
2023-11-07	RANIRani Therapeutics Holdings, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+2,500 sh	$2.01	+$5,025	449,455
2023-03-27	RANIRani Therapeutics Holdings, Inc.A Award	Director, Chief Executive Officer	AAward	+354K sh	—	—	444,445
2023-03-27	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+576K sh	—	—	575,600
2023-03-22	RANIRani Therapeutics Holdings, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−7,988 sh	$5.95	−$47.5K	90,945
2022-03-22	RANIRani Therapeutics Holdings, Inc.A Award	Director, Chief Executive Officer	AAward	+86.6K sh	—	—	98,943
2022-03-22	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+263K sh	—	—	263,400
2022-02-03	RANIRani Therapeutics Holdings, Inc.J Other	Director, Chief Executive Officer	JOther	−827K sh	—	—	0
2022-02-03	RANIRani Therapeutics Holdings, Inc.J Other	Director, Chief Executive Officer	JOther	+12.3K sh	—	—	12,343
2021-09-09	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+725K sh	—	—	725,000

Recent filings

Accepted (ET)
Sep 294
Imran Talat0001193125-26-407684
SEC(opens sec.gov)
Jul 214
Imran Talat0001869579-26-000006
SEC(opens sec.gov)
Jul 214
Imran Talat0001869579-26-000007
SEC(opens sec.gov)
Jun 54
Imran Talat0001869579-26-000003
SEC(opens sec.gov)
May 234
Imran Talat0000950170-25-077179
SEC(opens sec.gov)
Dec 104
Imran Talat0000950170-24-134828
SEC(opens sec.gov)
Mar 224
Imran Talat0000950170-24-035573
SEC(opens sec.gov)
Dec 194
Imran Talat0000950170-23-071472
SEC(opens sec.gov)

Companies

Rani Therapeutics Holdings, Inc.Director, Chief Executive OfficerRANI

Address

C/O RANI THERAPEUTICS LLC 2051 RINGWOOD AVE

SAN JOSE, CA, 95131